Olanzapine Tablet, Orally Disintegrating
Product Images NDC 64380-173

5 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 64380-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (70e79328 Ed14 40f4 8bbe D631b8943dd8 01)

Chemical Structure (70e79328 Ed14 40f4 8bbe D631b8943dd8 01)
Chemical structure of olanzapine, the active ingredient in the Olanzapine orally disintegrating tablet by Strides Pharma Science Limited.*
FDA Label Image

Image (70e79328 Ed14 40f4 8bbe D631b8943dd8 02)

Image (70e79328 Ed14 40f4 8bbe D631b8943dd8 02)
The label for Olanzapine Orally Disintegrating Tablets, USP 5 mg, shows a 30 unit dose carton with 3 blister cards each containing 10 tablets. The label includes the NDC number 64380-172-02, directions for use, storage conditions, phenylketonurics warning, and is distributed by Strides Pharma Inc. in East Brunswick, NJ.*
FDA Label Image

Image (70e79328 Ed14 40f4 8bbe D631b8943dd8 03)

Image (70e79328 Ed14 40f4 8bbe D631b8943dd8 03)
Packaging label for Olanzapine Orally Disintegrating Tablets USP, 10 mg strength. The package contains 30 unit dose tablets, divided into 3 blister cards each containing 10 tablets. Labeler is Strides Pharma Science Limited. The label includes directions to peel back foil to remove tablets and storage instructions.*
FDA Label Image

Principal Display Panel 15 mg (70e79328 Ed14 40f4 8bbe D631b8943dd8 04)

Principal Display Panel 15 mg (70e79328 Ed14 40f4 8bbe D631b8943dd8 04)
Packaging label for Olanzapine Orally Disintegrating Tablets USP 15 mg by Strides Pharma Science Limited. The carton contains 30 unit dose tablets (3 blister cards each with 10 tablets). The label includes storage instructions, phenylketonurics warning, and illustrated directions for tablet removal and administration.*
FDA Label Image

Principal Display Panel 20 mg (70e79328 Ed14 40f4 8bbe D631b8943dd8 05)

Principal Display Panel 20 mg (70e79328 Ed14 40f4 8bbe D631b8943dd8 05)
Olanzapine Orally Disintegrating Tablets, USP 20 mg packaging carton by Strides Pharma Science Limited. The label indicates a 30 unit dose tablet package (3 blister cards of 10 tablets each). Instructions for removing tablets from blister packaging are shown. The label includes storage instructions and a phenylketonurics warning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.